Method for reducing virus shedding, tissue colonization, and lymphoid depletion caused by or associated with PCV2 infection
TW202641835APending Publication Date: 2026-10-16BOEHRINGER INGELHEIM VETMEDICA GMBH
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114143038
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-11-06
- Filing Date
- 2025-11-05
- Publication Date
- 2026-10-16
Smart Images

Figure TWG2TA001080585_001 
Figure TWG2TA001080585_002 
Figure TWG2TA001080585_003
Abstract
(PCV2) infection in a pig, the method comprising administering orally to the pig an immunogenic composition comprising non-replicating PCV2 antigen. In one example, an immunogenic composition is administered via the oral route to a pig, wherein the immunogenic composition comprises a recombinantly produced and purified PCV2 ORF2 protein. This allows to simply reduce virus shedding, colonization of lymphoid tissue, and / or lymphoid depletion caused by associated with a PCV2 infection in the pigs, while simultaneously reducing the propensity for adverse reactions, eliminating the risk of injection site reactions, avoiding pain, and putting less stress on the animals.
Need to check novelty before this filing date? Find Prior Art
